Skip to content

PHARMACIE JANSSEN

Active
Private limited companyfounded 2024active for 1 yearVoie de Messe 19, 4680 Oupeye, BelgiumKBO/BCE: BE 1017.684.309
Summary

PHARMACIE JANSSEN has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €23,825 and a net result of €18,825. Its solvency ranks better than 25% of 22,773 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Overview

Official details

Source: KBO
Status
Active since 19-12-2024 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.367.771.087 4680 Oupeye, since 19-12-2024
Financial year end
31 December
Peppol
Reachable since 18-11-2025

Board and ownership

Board

Financial position

65 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.1%
Annual accounts 2025
Gross margin
€156,285
Turnover
≈ €490,000
estimated
Profit
€18,825
Equity
€23,825
Total assets
€518,745
Employees on 31-12-2025
2
Filed on 23-06-2026, 38 days before the deadline
Score breakdownraises riskFounded in 2024Equity €23,825 (4.6% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: total assets €518,745Show the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 38% of micro companies in retail trade (NACE 47)
Financial strength
Average
Solvency 30
equity 4.6% of total assets
Liquidity 35
short-term debt 50.2% · cash 8.3%
Profitability 73
return on assets 3.6%
Bankruptcy probability within 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 01-2026: 1.8% 02-2026: 1.8%● unchanged vs 01-2026 03-2026: 1.9%▲ +0.1 percentage points vs 02-2026 04-2026: 2.2%▲ +0.3 percentage points vs 03-2026 05-2026: 2.3%▲ +0.1 percentage points vs 04-2026 06-2026: 2.6%▲ +0.3 percentage points vs 05-2026 07-2026: 2.6%● unchanged vs 06-2026 08-2026: 2.8%▲ +0.2 percentage points vs 07-2026highest value 09-2026: 2.8%● unchanged vs 08-2026 10-2026: 1.1%▼ -1.7 percentage points vs 09-2026lowest value 11-2026: 1.1%● unchanged vs 10-2026lowest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.61, below 1. Short-term debt is 50.2% and cash 8.3% of total assets. 95.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 22% of them on solvency, 32% on liquidity and 58% on profitability.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: total assets €518,745
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €23,825 (4.6% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
38 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Higher gross margin than 87% of companies in retail tradesector median €34,182 · 22,708 companies €156,285 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointment: JANSSEN Sophie Betty Janine (director) · Permanent representative: JANSSEN Sophie Betty Janine
All 2 events

Comparable companies

These companies have the same main activity as PHARMACIE JANSSEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €466,000 and €573,000, founded between 2023 and 2025.

CompanyTotal assetsGross margin
PHARMACIE JANSSEN Oupeye€518,745€156,285
PHARMACIE BROMAN Montigny-le-Tilleul€481,857€150,911
WOLFS PHARMA Liège€509,540€131,915
ESPERANTO Ledegem€573,018€191,859
Apotheek Van den Bergh Kontich€516,952€184,631
PHARMACIE DE BERLOZ Berloz€466,197€129,768
PHARMACIE DU PETIT MOULIN Seneffe€471,907€114,484
Full comparison

Key facts about PHARMACIE JANSSEN

What is the company number of PHARMACIE JANSSEN?
The company number of PHARMACIE JANSSEN is 1017.684.309. The VAT number is the same number with BE in front: BE 1017.684.309.
Where is PHARMACIE JANSSEN based?
The registered office is at Voie de Messe 19, 4680 Oupeye.Company details
What does PHARMACIE JANSSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE JANSSEN?
The legal form of PHARMACIE JANSSEN is Private limited company (BV).
When was PHARMACIE JANSSEN founded?
PHARMACIE JANSSEN was founded on 19-12-2024.
Is PHARMACIE JANSSEN still active?
Yes, PHARMACIE JANSSEN is an active enterprise in the KBO register.
How many employees does PHARMACIE JANSSEN have?
PHARMACIE JANSSEN had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE JANSSEN fall under?
In its 2025 annual accounts, PHARMACIE JANSSEN states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of PHARMACIE JANSSEN?
The turnover in financial year 2025 is ≈ €490,000. This figure is estimated from the gross margin of €156,285 and 32 comparable companies (NACE 477). It probably lies between €340,000 and €970,000.
Is PHARMACIE JANSSEN profitable?
In financial year 2025, PHARMACIE JANSSEN made a profit of €18,825.
Where can I find the annual accounts of PHARMACIE JANSSEN?
PHARMACIE JANSSEN filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.